Aurobindo Pharma Ltd.’s first-quarter profit rose, in-line with analysts’ estimates.The Hyderabad-based bulk and generic drug maker’s net profit rose 10% year-on-year to Rs 571 crore in the quarter ended June, according to an exchange filing. That compares with the Rs 557-crore consensus estimate of analysts tracked by Bloomberg.Sequentially, it rose 13%.
The Israel government and Ramat Gan Municipality have reached an agreement in which the Ramat Gan Safari Park will...
Founder Suresh Bansal described it as a strategic milestone toward a sustainability-first global packaging ecosystem. DCGpac plans to expand its smart...
We came across a bullish thesis on Nu Holdings Ltd. on Global Equity Briefing’s Substack by Ray Myers. In this article,...
New York-listed shares of Infosys Ltd. surged over 8% on Wednesday after India's second largest IT firm announced its third...
The combined market valuation of seven of the top-10 most valued firms eroded by Rs 3,63,412.18 crore last week, with...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
